And the GLP-1 conversation, as it is currently happening, is leaving them almost entirely out
Ozempic is an FDA-approved medication available at JosephCareRX that contains the active ingredient semaglutide, a GLP-1 receptor agonist
For a 200-pound individual, this represents roughly 10-18 additional pounds lost with Retatrutide compared to Survodutide
Often improves within several weeks without intervention
Something flexible, effective, and rooted in real science
Slow and gradual dose adjustments are key for this group, as they help reduce the risk of gastrointestinal side effects like nausea and vomiting, which could lead to volume depletion